Clinical Trial Update: Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study assessing neoadjuvant ADI-PEG 20 plus ifosfamide and radiotherapy in soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• ADI-PEG 20 (pegylated arginine deiminase)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Soft Tissue Sarcoma, Sts | Phase 1 | Status: ACTIVE_NOT_RECRUITING